IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

NCT00351949 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage IV Renal Cell Carcinoma

Interventions

BIOLOGICAL: IMP321

Sponsor

Immutep S.A.S.

Collaborators

[object Object]